Mirum Pharmaceuticals Inc share price logo

Mirum Pharmaceuticals Inc Share Price

NASDAQ: MIRM

Mid Cap

$73.07

-0.46

(-0.63%)

as on

Mirum Pharmaceuticals Inc Stock Performance

as on October 21, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $72.1
    $74.33
    downward going graph

    1.33%

    Downside

    1.72%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $36.88
    $78.54
    downward going graph

    49.53%

    Downside

    7.49%

    Upside

    downward going graph

Mirum Pharmaceuticals Inc share price movements today

Previous Close
$73.53
Open
$74.15
Volume
348.4K
Day's Low - High
$72.1 - $74.33
52 Week Low - High
$36.88 - $78.54

Mirum Pharmaceuticals Inc Historical Returns

1 Month Return
-1.14 %
3 Month Return
+ 41.59 %
1 Year Return
+ 86.34 %
3 Year Return
+ 270.43 %
5 Year Return
+ 303.35 %

Mirum Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Mirum Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.7B

EPS (TTM)

-0.6943

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-18.35

Industry PE ratio

8.355964912280701

PEG Ratio

0

EBITDA

-32.9M

Revenue (TTM)

429.2M

Profit Margin

-13.65%

Return On Equity TTM

0.00%

Mirum Pharmaceuticals Inc Stock Valuation

Track how Mirum Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Mirum Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (-69.86x)

September 30, 2025

Today (-18.35x)

October 20, 2025

Industry (8.36x)

October 20, 2025

Highest (-2.45x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -18.35x

Mirum Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mirum Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.7B303.35%-18.35-13.65%
BUY$63.1B240.52%-505.15-12.96%
NA$35.3BNANA-3.89%
BUY$106.9B94.28%29.6731.86%
BUY$61.3B0.25%14.5831.37%

Stock Returns calculator for Mirum Pharmaceuticals Inc Stock including INR - Dollar returns

The Mirum Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Mirum Pharmaceuticals Inc investment value today

Current value as on today

₹1,89,905

Returns

₹89,905

(+89.9%)

Returns from Mirum Pharmaceuticals Inc Stock

₹85,175 (+85.17%)

Dollar Returns*

₹4,730 (+4.73%)

Analyst Recommendation on Mirum Pharmaceuticals Inc Stock

Based on 17 analysts

BUY

94.12%

Buy

5.88%

Hold

0.00%

Sell

Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Mirum Pharmaceuticals Inc. Average target price of $83.55

Mirum Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Mirum Pharmaceuticals Inc.

What analysts predicted

12.54%UPSIDE

Target Price

$83.55

Current Price

$73.07

Analyzed by

17 Analysts

Target

$83.55

Mirum Pharmaceuticals Inc target price $83.55, a slight upside of 12.54% compared to current price of $73.07. According to 17 analysts rating.

Mirum Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Mirum Pharmaceuticals Inc Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-32% versus previous 30 day period

Mirum Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
31
37
47
69
69
77
90
99
111
127
Gross Profit
26
30
37
46
51
57
69
76
88
104
Operating Income
-27
-24
-25
-30
-26
-24
-12
-24
-15
-4
EBITDA
-24
-68
-17
-26
-15
-14
-4
-14
-4
4
Interest Expense
4
3
3
3
3
3
3
3
3
3
Depreciation
1
1
2
5
5
5
6
6
6
6
Income Before Tax
-29
-73
-23
-32
-24
-24
-13
-24
-13
-5
Income Tax Expense
0
0
0
0
0
0
0
0
1
0
Net Income
-30
-74
-23
-33
-25
-24
-14
-23
-14
-5
Net Profit Margin
-95.35%
-197.45%
-49.42%
-47.66%
-36.52%
-31.64%
-15.75%
-23.93%
-13.15%
-4.59%

Mirum Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
11
19
77
186
336
Gross Profit
-
0
0
17
64
139
255
Operating Income
-2
-54
-104
-173
-131
-109
-87
EBITDA
-17
-54
-102
-65
-122
-136
-48
Interest Expense
-
2
0
17
15
15
14
Depreciation
-
0
0
0
3
6
23
Income Before Tax
-17
-52
-103
-83
-142
-162
-86
Income Tax Expense
-4
0
0
0
-6
0
1
Net Income
-17
-52
-103
-83
-135
-163
-87
Net Profit Margin
0.00%
0.00%
-938.82%
-438.85%
-176.05%
-87.68%
-26.10%

Mirum Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-74
-23
-33
-25
-24
-14
-23
-14
-5
Operating Cash Flow
-2
-18
-16
15
-3
3
-5
-1
12
Investing Cash Flow
35
-182
-2
0
-72
-18
0
-16
-6
Financing Cash Flow
114
207
1
1
7
3
5
6
8
Change in Cash
147
5
-16
16
-69
-9
0
-10
16

Mirum Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-52
-103
-83
-135
-163
-87
Operating Cash Flow
-39
-89
-132
-120
-70
10
Investing Cash Flow
-127
37
48
7
-107
-90
Financing Cash Flow
127
181
73
109
336
17
Change in Cash
-39
130
-10
-3
158
-63

Global Institutional Holdings in Mirum Pharmaceuticals Inc

Funds
Holdings
HHG PLC
10.42%
BlackRock Inc
7.12%
Bvf Inc
5.5%
Eventide Asset Management, LLC
5.25%
Vanguard Group Inc
5.11%

Insights on Mirum Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 69.22M → 127.78M (in $), with an average increase of 11.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MIRM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MIRM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, MIRM stock has moved up by 86.3%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -23.79M → -5.86M (in $), with an average increase of 106.3% per quarter

About Mirum Pharmaceuticals Inc

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california.
OrganisationMirum Pharmaceuticals Inc
Headquarters950 Tower Lane, Foster City, CA, United States, 94404
IndustryHealth Technology
CEOMr. Christopher Peetz
E-voting on sharesClick here to vote

Key Management of Mirum Pharmaceuticals Inc

Name

Title

Mr. Christopher Peetz

CEO & Director

Mr. Eric H. Bjerkholt M.B.A., M.S.

Chief Financial Officer

Mr. Andrew McKibben

Senior Vice President, Strategic Finance & Investor Relations

Ms. Lara Longpre MBA, MSC

Chief Development Officer

Ms. Erin Campany

Chief People Officer

Mr. Peter Radovich M.B.A., Ph.D.

COO & President

Dr. Joanne M. J. Quan M.D.

Chief Medical Officer

Dr. Jean-Luc Girardet Ph.D.

Chief Technical Officer

Mr. Paul K. Ross

Chief Compliance Officer

Mr. Douglas T. Sheehy J.D.

Chief Legal Officer

FAQs

What is Mirum Pharmaceuticals Inc share price today?

Mirum Pharmaceuticals Inc share price today is $73.07 as on at the close of the market. Mirum Pharmaceuticals Inc share today touched a day high of $74.33 and a low of $72.1.

What is the 52 week high and 52 week low for Mirum Pharmaceuticals Inc share?

Mirum Pharmaceuticals Inc share touched a 52 week high of $78.54 on and a 52 week low of $36.88 on . Mirum Pharmaceuticals Inc stock price today i.e. is closed at $73.07,which is 6.97% down from its 52 week high and 98.13% up from its 52 week low.

What is Mirum Pharmaceuticals Inc's market capitalisation today?

Mirum Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Mirum Pharmaceuticals Inc Stock (MIRM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mirum Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mirum Pharmaceuticals Inc Shares that will get you 0.0205 shares as per Mirum Pharmaceuticals Inc share price of $73.07 per share as on October 21, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mirum Pharmaceuticals Inc Stock (MIRM) from India?

Indian investors can start investing in Mirum Pharmaceuticals Inc (MIRM) shares with as little as ₹87.9 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Mirum Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Mirum Pharmaceuticals Inc share’s latest price of $73.07 as on October 21, 2025 at 1:29 am IST, you will get 0.1369 shares of Mirum Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Mirum Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Mirum Pharmaceuticals Inc stock has given 303.35% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?